{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-021086","form_type":"8-K","ticker":"PBYI","cik":"0001401667","company_name":"PUMA BIOTECHNOLOGY, INC.","filed_at":"2024-06-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.252034+00:00","generated_at":"2026-06-01T02:25:07.135717+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Puma Biotechnology shareholders approve 3M share increase for equity plan, elect directors","bullets":["Shareholders approved amendment to increase shares under 2011 plan by 3M to 17,529,412; ISO grants extended to March 2034.","All eight director nominees elected: Auerbach, Cesano, Dorval, Miller, Moyes, Senderowicz, Stuglik, Wilson.","Ratified KPMG as independent auditor for fiscal 2024 with 40.2M votes for.","Advisory say-on-pay approved with 30.7M for; board adopts annual frequency for future votes."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-021086","json":"https://secwatch.observer/filing/0001437749-24-021086.json","markdown":"https://secwatch.observer/filing/0001437749-24-021086.md","text":"https://secwatch.observer/filing/0001437749-24-021086.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924021086/0001437749-24-021086-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924021086/pbyi20240621_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T02:25:07.135717+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}